SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-19-000169
Filing Date
2019-09-12
Accepted
2019-09-11 20:08:45
Documents
14
Period of Report
2019-09-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-form8xk91219repur.htm   iXBRL 8-K 40592
  Complete submission text file 0000886163-19-000169.txt   183376

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20190911.xsd EX-101.SCH 4576
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20190911_cal.xml EX-101.CAL 616
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20190911_def.xml EX-101.DEF 1466
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20190911_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20190911_pre.xml EX-101.PRE 13572
12 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-form8xk91219repur_htm.xml XML 4265
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 191089335
SIC: 2834 Pharmaceutical Preparations